Skip to main content
Parker Cancer ends here

Published Research

Published Research

3 results for Science

Neoantigen-Driven Targeting

Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering

March 19, 2026

Stanford Medicine, University of California, Los Angeles

CRISPR-engineered T cells in Patients with Refractory Cancer

February 28, 2020

University of Pennsylvania